Skip to main content
Watch Insiders
PLSEHealthcare

Pulse Biosciences Inc (PLSE) Insider Trading

In the last 90 days, 1 Pulse Biosciences Inc (PLSE) insider reported 2 open-market purchases totaling $199,936 and no sales. The most recent open-market purchase was reported on Sep 1, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$199,936
Corporate buyers
1
Latest transaction
Sep 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 1, 2026Liane Rae TeplitskyChief Operating OfficerOpen Market Purchase2,025$49.37$99,971
Aug 28, 2026Liane Rae TeplitskyChief Operating OfficerOpen Market Purchase2,070$48.29$99,965
May 11, 2026Paul A LavioletteChief Executive OfficerOpen Market Purchase15,000$19.69$295,350
May 11, 2026Robert W DugganCorporate insiderOpen Market Purchase660,233$19.69$12,999,988

Common questions

PLSE insider trading FAQ

Are PLSE insiders buying or selling?
Over the last 90 days, PLSE insiders were net buyers, reporting $199,936 of open-market purchases and $0.00 of sales.
When was the last PLSE insider purchase?
The most recent open-market purchase of Pulse Biosciences Inc stock by an insider was reported on Sep 1, 2026, one of 2 purchases in the last 90 days.
Where does PLSE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Pulse Biosciences Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.